Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs 4 Hydroxyphenyllactic Aciduria C1848679
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and 4 Hydroxyphenyllactic Aciduria for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
4 Hydroxyphenyllactic Aciduria C1848679
A metabolic condition affecting how the body processes amino acids. Usually identified in early life. Managed through specialized diet and regular medical follow-up.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
4 Hydroxyphenyllactic Aciduria C1848679
Variable
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
4 Hydroxyphenyllactic Aciduria C1848679
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
4 Hydroxyphenyllactic Aciduria C1848679
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
4 Hydroxyphenyllactic Aciduria C1848679
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
4 Hydroxyphenyllactic Aciduria C1848679
metabolic
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
4 Hydroxyphenyllactic Aciduria C1848679
metabolic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and 4-hydroxyphenyllactic-aciduria-C1848679 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 4 Hydroxyphenyllactic Aciduria C1848679 | Discriminating power |
|---|---|---|---|
| Genital development | Undervirilization may occur in 46,XY individuals. | No established genital phenotype is described. | High |
| Metabolic presentation | Not primarily described as an amino-acid processing disorder. | Abnormal amino-acid handling may be identified, often early in life. | High |
| Course | Described as severe and chronic, with endocrine management. | Described as moderate and chronic, with dietary follow-up. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY undervirilization with suspected steroid-enzyme defect
The supplied description centers on isolated 17,20-lyase deficiency and androgen synthesis.
Moderate
Reproductive or endocrine evaluation
The concept is categorized as endocrine and reproductive rather than metabolic.
Moderate
Hormone-therapy planning
Management is described as hormone therapy, but specific regimens are not established here.
Low
Choose 4 Hydroxyphenyllactic Aciduria C1848679 when
Abnormal urine organic-acid or amino-acid result
The finding suggests disordered amino-acid processing but is not itself a definitive diagnosis.
Moderate
Early-life metabolic assessment
The source states identification is usually early, although onset is listed as variable.
Low
Dietary management discussion
Specialized diet and follow-up are described, without specifying a diet.
Low
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 4 Hydroxyphenyllactic Aciduria C1848679 | Interpretation |
|---|---|---|---|
| Steroid or androgen evaluation | May support impaired androgen synthesis if clinically indicated. | No expected steroid abnormality is established. | Results require specialist correlation; no cutoff is supplied. |
| Urine metabolite testing | Not the defining test in the supplied description. | May show 4-hydroxyphenyllactic acid or related abnormalities. | An abnormal result needs confirmation and does not alone establish disease. |
| Genetic or enzyme assessment | May be considered for the suspected enzyme deficiency. | May be considered if a metabolic disorder is suspected. | Choice and interpretation belong to a clinician; no specific test is mandated here. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- Chronic severe condition is described, but prognosis is not established.
- Factors
- Androgen deficiency, reproductive effects, and response to clinician-directed hormone care may matter.
4 Hydroxyphenyllactic Aciduria C1848679
- Outcome
- Chronic moderate condition or finding is described, but prognosis is not established.
- Factors
- Degree of metabolic abnormality, diet adherence, and follow-up may matter.
Time frame: Long-term course is implied, but no specific timeline is established.
Diagnosis confirmation, associated conditions, and individualized specialist care influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization-related effects | Possible because androgen synthesis is impaired. Not established from the supplied data. Exact manifestations and frequency are not provided. |
| Metabolic imbalance | Not described as the primary problem. Possible concern because amino-acid processing is affected. Severity and laboratory thresholds are not established here. |
| Long-term care needs | Chronic endocrine follow-up may be needed. Chronic metabolic follow-up and diet supervision may be needed. Neither outcome nor complication rate is quantified. |
Patient education highlights
- HighDifferent conditions
One concerns sex development and androgen synthesis; the other concerns a metabolic finding or amino-acid processing.
- HighAbnormal result versus diagnosis
A laboratory abnormality, especially aciduria, requires clinician confirmation before being treated as a diagnosis.
- MediumFollow-up
Both are described as chronic and noncommunicable, but management differs and should be individualized.